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Dale R. Nyholt8, Kijoung Song9, Sita H. Vermeulen10,11, Stavroula Kanoni12, George Dedoussis13,
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The pathogenesis of androgenetic alopecia (AGA, male-pattern baldness) is driven by androgens, and genetic
predisposition is the major prerequisite. Candidate gene and genome-wide association studies have reported that
single-nucleotide polymorphisms (SNPs) at eight different genomic loci are associated with AGA development.
However, a significant fraction of the overall heritable risk still awaits identification. Furthermore, the under-
standing of the pathophysiology of AGA is incomplete, and each newly associated locus may provide novel insights
into contributing biological pathways. The aim of this study was to identify unknown AGA risk loci by replicating
SNPs at the 12 genomic loci that showed suggestive association (5 10 8oPo10 5) with AGA in a recent meta-
analysis. We analyzed a replication set comprising 2,759 cases and 2,661 controls of European descent to confirm
the association with AGA at these loci. Combined analysis of the replication and the meta-analysis data identified
four genome-wide significant risk loci for AGA on chromosomes 2q35, 3q25.1, 5q33.3, and 12p12.1. The strongest
association signal was obtained for rs7349332 (P¼ 3.55 10 15) on chr2q35, which is located intronically inWNT10A.
Expression studies in human hair follicle tissue suggest that WNT10A has a functional role in AGA etiology. Thus,
our study provides genetic evidence supporting an involvement of WNT signaling in AGA development.
Journal of Investigative Dermatology (2013) 133, 1489–1496; doi:10.1038/jid.2013.43; published online 14 March 2013
INTRODUCTION
Androgenetic alopecia (AGA, male-pattern baldness, Online
Mendelian Inheritance in Man (OMIM 109200), OMIM
3010710, and OMIM 612421) is the most common form of
hair loss in humans, and affects 80% of European men by
the age of 80 years. AGA is characterized by a progressive
loss of hair from the scalp (Hamilton, 1951; Norwood, 1975),
and changes in hair cycling are a key feature of its
pathophysiology (Kaufman, 2002; Randall, 2007). Research
has established that the two major etiological factors for AGA
are genetic predisposition and hormonal status (Hamilton,
1942, 1951). The heritability of AGA is high, and has been
estimated to be B80% in two independent twin studies
(Nyholt et al., 2003; Rexbye et al., 2005). Candidate gene
and genome-wide association studies (GWASs), including a
recent meta-analysis of seven GWASs, have identified
strong associations between AGA and single-nucleotide
polymorphisms (SNPs) at eight chromosomal loci (Ellis and
Harrap, 2001; Hayes et al., 2005; Hillmer et al., 2005,
2008a,b; Levy-Nissenbaum et al., 2005; Prodi et al., 2008;
Richards et al., 2008; Brockschmidt et al., 2010; Brockschmidt
et al., 2011; Li et al., 2012). Of these, the X-chromosomal
androgen receptor/ectodysplasin A2 receptor locus (AR/
EDA2R) confers the strongest effect, and the androgen
receptor is a highly plausible candidate gene at this locus.
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However, no study has demonstrated an effect of genetic
variation on the expression and function of the protein.
Similarly, for the seven autosomal loci, in some cases candi-
date genes have been suggested, such as histone deacetylase 9
on chromosome (chr) 7p21.1 (Brockschmidt et al., 2011;
Li et al., 2012) and histone deacetylase 4 on chr2q37.3
(Li et al., 2012), but no direct functional evidences have
been obtained so far. Despite these recent breakthroughs
in our understanding of the genetics of AGA, a significant
fraction of the overall heritable risk still awaits identification.
The identification of additional risk factors is highly desirable,
as these may provide new insights into the pathophysiology of
AGA and its underlying biological pathways. A promising
strategy for the identification of additional genomic loci for
AGA is to replicate SNPs at the genomic loci that showed
suggestive association with AGA within the meta-analysis by
Li et al. (2012) (Po105), but which fell above the threshold
for genome-wide significance (P¼ 510 8). This study
involved two independent samples: first a German AGA
case–control sample comprising 177 AGA cases and 272
supercontrols (460 years, no signs of AGA), and second a
sample of European descent comprising 2,582 AGA cases and
2,389 controls.
RESULTS
Analysis of the data from the MAAN (Meta-Analysis for
Androgenetic Alopecia Novel Determinants) by Li et al.
(2012) revealed a total of 12 genomic loci for which at least
one SNP showed an association with AGA of Po1 10 5 but
fell short of genome-wide significance (P45 10 8; Table 1).
For each of these 12 loci, the two SNPs with the best
association P-values in the meta-analysis were genotyped in
an independent German replication sample (‘‘Replication I’’).
Of the 24 SNPs, 21 were genotyped successfully for 177 cases
and 272 supercontrols. Of these, three SNPs at two distinct
genomic loci showed nominally significant association with
AGA (Po0.05; Table 1). However, only rs7349332 on
chr2q35 showed a genome-wide significant association in a
combined analysis of our data and the data of the previous
meta-analysis (P¼3.32109; data not shown). We there-
fore attempted further replication using data from the scientific
program of 23andMe (23andWe). All 24 SNPs were analyzed
within the existing genome-wide data of 2,582 cases and
2,389 controls of European descent from 23andMe (‘‘Replica-
tion II’’). Of these, a total of 12 SNPs at 6 distinct genomic loci
showed a nominally significant association with AGA
(Table 1). A combined analysis of the two replication studies
and the published meta-analysis (Li et al., 2012) established
genome-wide significant association with AGA for the regions
on chr2q35, chr3q25.1, chr5q33.3, and chr12p12.1 (Table 1,
Figure 1). The strongest association was observed for
rs7349332 on chr2q35 (P¼ 3.55 10 15; odds ratio
(OR)¼ 1.34, 95% confidence interval (CI)¼1.27–1.42),
which is located intronically in WNT10A (wingless-type
MMTV integration site family, member 10A) (Figure 1a). This
association finding on chr2q35 was further supported by
rs10193725 (P¼1.461010; OR¼ 0.80, 95% CI¼ 0.74–
0.87), which is located B30 kb upstream of rs7349332 and
intronically within WNT6, another member of the wingless-
type MMTV integration site family. The AGA risk allele (T) for
rs7349332 was associated with hair curl in two independent
GWASs (Medland et al., 2009; Eriksson et al., 2010). To
investigate a potential etiological overlap between AGA and
hair curl, we analyzed whether any other genome-wide
significant loci for hair curl were associated with AGA, and
whether any genome-wide significant loci for AGA were asso-
ciated with hair curl. Aside from rs7349332 in WNT10A, there
were no associations with Po0.05 after adjusting for multiple
comparisons. The second best association was observed for a
locus on chr5q33.3 comprising the two SNPs rs929626
(P¼ 2.12 10 11; OR¼0.84 95% CI¼0.79–0.89) and
rs1081073 (P¼8.52109; OR¼ 1.17, 95% CI¼1.12–
1.22), both of which are located intronically within EBF1
(early B-cell factor 1) (Figure 1c). On chr12p12.1, the best
association signal was observed for rs9668810, with P¼1.09
 1010 (OR¼1.21, 95% CI¼ 1.15–1.27), followed by the
2.3-kb distal rs7975017 (P¼4.031010; OR¼ 1.21, 95%
CI¼ 1.15–1.28). Both SNPs on chr12p12.1 are located in
the intergenic region between the two RefSeq genes SSPN
(sarcospan) and ITPR2 (inositol 1,4,5-triphosphate receptor,
type 2) (Figure 1d). A similarly strong association signal
was identified for a locus on chr3q25.1, with P-values of
P¼1.791010 (OR¼ 1.19, 95% CI¼1.13–1.24) and
P¼1.20109 (OR¼1.18, 95% CI¼1.12–1.23) for
rs7648585 and rs4679955, respectively. Both SNPs are
located in the intergenic region between the two RefSeq
genes SUCNR1 (succinate receptor 1) and MBNL1 (muscle-
blind-like splicing regulator 1) (Figure 1b). Although the
direction of effects was consistent across all studies for the
region on chr12q24.33 flanked by the two RefSeq genes
TMEM132D (transmembrane protein 132D) and FZD10
(frizzled family receptor 10), this region failed to reach
genome-wide significance in the combined analysis
(Pmin¼1.28106).
In a second step, we investigated the expression of RefSeq
genes located within a 200 kb window around the SNP with
the lowest P-value at the respective AGA risk loci within
human hair follicles (Table 2). On chr2q35, eight RefSeq genes
were located within this 200 kb window. Of these, two genes
showed expression in human hair follicle. The highest expres-
sion values were observed for CYP27A1 (cytochrome P450,
family 27, subfamily A, polypeptide 1; average (AVG)
signal¼377.21), which is located 76.4kb downstream of
rs7349332. Hair follicle expression was also detected for
WNT10A—which spans rs7349332—with an AVG signal of
86.36. On chr3q25.1 and chr5q33.3, no expression was
detected for the investigated genes, i.e., SUCNR and EBF1,
respectively. On chr12p12.1, both of the genes that flank the
association finding showed expression in hair follicles. SSPN,
which is locatedB38.7 kb downstream of rs9668810, showed
an AVG signal of 70.55, and ITPR2, which is locatedB61.9kb
downstream of rs9668810, showed an AVG signal of 119.04.
We also tested for a genotypic effect on the expression of
candidate genes showing expression in hair follicles. Interest-
ingly, we observed a genotypic effect of rs7349332 on
the expression of WNT10A, in which AGA risk allele carriers
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(CT, TT; n¼ 25) showed significantly reduced expression
compared with nonrisk allele carriers (CC; n¼ 71; P¼0.03;
Figure 2). We detected no genotypic effect of rs7349332
or rs9668810 on the expression of CYP27A1 or SSPN,
respectively (data not shown). The observed tendency toward
a lower expression of ITPR2 in homozygous AGA risk allele
carriers (TT) for rs9668810 was not statistically significant
(P¼ 0.09; data not shown). To better understand the role
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Figure 1. Local association plots for the identified androgenetic alopecia (AGA) risk loci. Regional association results for the identified AGA risk loci on
chromosomes (a) 2q35, (b) 3q25.1, (c) 5q33.3, and (d) 12p12.1. Each panel shows the  log10(P) of single-nucleotide polymorphisms (SNPs) against their
chromosomal (chr) position. For the SNPs included in the replication analysis, association results for the published meta-analysis data (Li et al., 2012) are depicted
as squares (PMAAN), and the results of the combined analysis are depicted as diamonds (Pcombined). The lead SNP at each locus is denoted in purple; the color of
other SNPs indicates the linkage disequilibrium (LD) with lead SNP as red (0.8pr2p1), orange (0.6pr2o0.8), green (0.4pr2o0.6), light blue (0.2pr2o0.4), and
dark blue (r2o0.2).
Table 2. Average expression signals for RefSeq genes located 100kb upstream and downstream of the SNP with the lowest P-value at the
respective AGA risk loci
Gene Chr Start Stop Illumina probe ID AVG signal Detection P-value
CYP27A1 2 219,646,471 219,680,016 ILMN_1704985 377.21 1.30E03
PRKAG3 2 219,687,105 219,696,512 ILMN_1716754 — 40.01
WNT6 2 219,724,545 219,738,954 ILMN_1795706 — 40.01
WNT10A 2 219,745,254 219,758,651 ILMN_1658426 86.36 2.60E03
CDK5R2 2 219,824,397 219,826,877 ILMN_1717803 — 40.01
LOC151300 2 219,841,005 219,842,644 ILMN_3289895 — 40.01
FEV 2 219,845,808 219,850,379 ILMN_1751460 — 40.01
CRYBA2 2 219,854,911 219,858,127 ILMN_2260313 — 40.01
SUCNR1 3 151,591,430 151,599,876 ILMN_1681601 — 40.01
EBF1 5 158,122,922 158,526,788 ILMN_1778681 — 40.01
SSPN 12 26,348,268 26,387,708 ILMN_1775486 70.55 2.60E03
ITPR2 12 26,488,284 26,986,131 ILMN_1736103 119.04 2.60E03
Abbreviations: AGA, androgenetic alopecia; AVG, average; Chr, chromosome; OR, odds ratio; SNP, single-nucleotide polymorphism.
Genes located closest to the best association finding at the respective locus are printed in bold. All genomic positions are according to GRCh37/hg19.
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of WNT10A and other WNT-related genes in the etiology of
AGA, we also examined the interaction between the lead
SNPs from loci in close proximity to genes related to WNT
signaling (i.e., WNT6, WNT10A, WNT3, and FZD10). More-
over, we examined the interactions between the lead SNPs
from the eight previously identified AGA risk loci (Li et al.,
2012), the four risk loci identified in this study, and the locus
on chr12q24.33 (FZD10). We did not detect any interaction
between rs7349332 (WNT10A) and any of the other loci;
however, restricting the analysis to loci related to WNT
signaling revealed a significant interaction between
rs745077 (FZD10) and rs12373124 (WNT3) (P¼0.02; data
not shown).
DISCUSSION
This study identified four AGA risk loci with genome-wide
significance on chromosomes 2q35, chr3q25, chr5q33.3, and
chr12p12.1, and provides biological evidence that WNT10A
is the gene responsible for the effect on chr2q35. WNT10A is
a member of the family of WNT genes that encode small
secreted signaling proteins. These proteins participate
in diverse developmental processes during embryogenesis,
as well as in adult tissue homeostasis (Logan and Nusse,
2004). Numerous publications have indicated the importance
of WNT signaling in hair development and hair cycling (Millar
et al., 1999; Reddy et al., 2001; Andl et al., 2002; Fuchs,
2007). In particular, some authors have suggested that WNT
signaling constitutes an important regulatory signal for the
transition from telogen to anagen in postnatal hair follicles
(Reddy et al., 2001; Li et al., 2011). Interestingly, WNT10A
expression has been detected at anagen onset in mouse hair
follicles (Reddy et al., 2001), suggesting that WNT10A is
implicated in anagen induction. A study by Shimizu and
Morgan (2004) showed that WNT signaling is essential in the
maintenance of anagen characteristics within dermal papilla
cells. This finding is of particular interest, as changes in hair
follicle dynamics are a key feature of AGA (Courtois et al.,
1994). During AGA development, the premature transition
from anagen to telogen results in shorter hair growth phases
and a reduction in the ratio of anagen to telogen follicles
(Whiting, 1993; Courtois et al., 1994; Kaufman, 2002).
Moreover, the time interval between telogen and the
initiation of a new hair cycle is prolonged, leading to a
decrease in hair density (Ellis et al., 2002). The regulation of
hair cycle dynamics might be a plausible mechanism for how
rs7349332 confers risk for AGA. The decrease in WNT10A
expression observed in AGA risk allele carriers for rs7349332
might lead to a delay in telogen–anagen transition and a
shortening of anagen duration, resulting in the changes in hair
cycling described for AGA (Figure 3). The role of WNT
signaling in AGA etiology is further supported by the fact that
other genes related to WNT signaling are located in the
vicinity of other AGA risk loci, e.g., WNT3 on the previously
implicated chromosomal region chr17q21.31 and ITPR2 on
chr12p12.1 implicated in our present study. Research suggests
that the latter might act downstream of WNT signaling as a
receptor for IP3 (Wang and Malbon, 2004). Interestingly,
another member of the IP3 receptor family has recently been
proposed to actively regulate the process of hair shedding
(Sato-Miyaoka et al., 2012). Moreover, the locus on
chr12q24.33 that shows evidence for association in our
study—although not with genome-wide significance (P¼1.28
 106)—harbors FZD10, which encodes a known WNT
receptor. Observations from clinical genetics also suggest that
WNT10A may be implicated in hair growth. Homozygous
mutations in WNT10A are a known cause of autosomal
recessive odonto-onycho dysplasia (OMIM 257980 and
OMIM 606268), which may present with sparse scalp
and body hair (Adaimy et al., 2007; Bohring et al., 2009).
Additional support for a role of WNT signaling in the etiology
of AGA, although preliminary, was provided by our
interaction analysis suggesting an interaction of FZD10
and WNT3.
Expression of WINT10A at rs7349332
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Figure 2. Genotype-specific expression analysis of WNT10A at rs7349332.
Boxplots indicate the distribution of the normalized expression data for the
respective genotype group (CC, n¼ 71; CT, n¼ 24; TT, n¼ 1). Genotype-
specific expression levels were calculated from the normalized fluorescence-
intensity signals for WNT10A (ILMN_1658426) relative to the average
expression level of rs7349332 nonrisk genotype (CC) carriers, which was set to
100%. The bold horizontal line indicates the median value; limits of the
rectangle indicate lower and upper quartiles. End points of the dashed
vertical lines indicate the minimum and maximum expression values. Outliers
(i.e., values deviating41.5-fold the interquartile range from the median value)
are depicted by circles. Androgenetic alopecia (AGA) risk allele carriers for
rs7349332 show significantly lower expression of WNT10A (P¼ 0.03).
Anagen
Catagen
Telogen
Impaired WNT
signaling
(e.g., WNT10A)
Deregulated hair
cycle dynamics
AGAHealthy hair cycledynamics
Figure 3. Proposed model for the functional role of WNT10A in the
regulation of hair cycle dynamics. WNT10A promotes anagen induction and
maintenance of anagen state. A reduction in WNT10A expression leads to
deregulation of the healthy hair cycle, a delay in telogen to anagen transition,
and shortening of the anagen phase, as observed in androgenetic alopecia
(AGA) hair follicles.
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Although our data and evidence from the literature suggests
that WNT10A is involved in the etiology of AGA, any such
role needs to be substantiated by additional studies including
detailed functional studies or, at the genetic level, by identify-
ing independently associated WNT10A alleles through
resequencing and high-resolution association studies.
The association finding on chr2q35 also suggests an
unexpected link between AGA and hair structure. The AGA
risk allele (T) of rs7349332 was associated with curly hair in
two independent GWAS studies (Medland et al., 2009;
Eriksson et al., 2010). To our knowledge, no previous study
has reported an association between AGA and curly hair at
either a clinical or an epidemiological level. GWA studies
enable investigation of whether this identified link is restricted
to the WNT10A locus or whether it is more widespread,
affecting additional genomic loci. As a preliminary step in this
direction, we investigated whether the other genome-wide
significant loci for AGA and curly hair were associated
with the risk for the other trait. As this was not the case, the
etiological overlap between the two traits may specifically
involve the WNT signaling pathway. This hypothesis requires
comprehensive investigation in large GWAS data sets.
In summary, this study provides genetic evidence for a
contribution of WNT signaling to AGA etiology. We demon-
strated that the AGA risk variant rs7349332 had a regulatory
effect on WNT10A expression in the human hair follicle. This
effect might be of functional relevance in the regulation of hair
cycle dynamics. As WNT signaling has been implicated in a
number of human disorders (Clevers and Nusse, 2012), this
pathway might account for some of the unexpected
associations of AGA with common traits as described
by Li et al. (2012). The candidate genes for the genetic loci
3q25.1 and 5q33.3 remain unknown. Further studies using
complementary strategies, such as re-sequencing and
functional studies, are needed to identify these candidate
genes and to further elucidate the actual functional causes that
underlie these disease associations. As exemplified by the
WNT10A finding, the identification of candidate genes on the
basis of genetic association studies may provide new insights
into AGA pathophysiology.
MATERIALS AND METHODS
Samples and DNA extraction
This replication study included two independent samples of European
descent. For the ‘‘Replication I’’ sample, peripheral blood samples
were collected from 177 unrelated AGA-affected males and 272
AGA-unaffected controls, all of German descent. The hair status of
each participant was assessed by a dermatologist according to the
Hamilton/Norwood (HN) classification. Affected men were aged
o30 years with HN grades IV–VII, or o40 years with HN grades
V–VII, and were thus representative of the most severely affected 10%
of the distribution for the respective age classes (Hamilton, 1951;
Norwood, 1975). The controls were aged460 years and showed no
signs of AGA, and were thus representative of the 20% least affected
individuals in the population. DNA from lymphocytes was isolated by
salting out with saturated NaCl solution (Miller et al., 1988), or using
Chemagic Magnetic Separation Module I (Chemagen, Baesweiler,
Germany) according to the manufacturer’s instructions. The second
sample (‘‘Replication II’’) comprised unrelated male individuals of
European descent, selected from users of the 23andMe Personal
Genome Service (Eriksson et al., 2010). The affection status for AGA
was measured by self-assessment through a web-based survey.
Individuals with HN grade XIII and age of onset o40 years were
defined as cases (n¼ 2,582), and individuals with HN grade I and age
X30 or HN grade II and age X50 were considered as controls
(n¼ 2,389). Individuals related to any individual included in our
previous AGA meta-analysis (Li et al., 2012) were also excluded. A
summary of the case–control samples used in this study is provided in
Supplementary Table S1 online. All studies were approved by the insti-
tutional ethics review committees of the respective organizations. The
studies were conducted in accordance with the Declaration of Helsinki
Principles, and all participants provided written informed consent.
Genotyping
Genotyping for the ‘‘Replication I’’ sample was carried out on
Sequenom’s Mass Array System (Sequenom, San Diego, CA) using
the iPlex Gold assay in a multiplex reaction. On the basis of the
association signals obtained in the meta-analysis (Li et al., 2012),
12 loci were selected, for which at least one SNP had attained an
association signal of 5 10 8oPo1 10 5. For each locus, the
two SNPs with the best association signals were selected for
replication. SNP call rates of 90% were required for the analysis,
and samples with call rates of o90% were excluded. Genotyping
was successful for 21 of the 24 SNPs. All samples had genotyping call
rates of 490%. Primer sequences and standard assay conditions are
available upon request. Genotyping for the ‘‘Replication II’’ sample
was performed using Illumina (San Diego, CA) genome-wide SNP
arrays as previously described (Li et al., 2012). A total of 315
individuals were genotyped using a custom version of the Illumina
HumanHap550 array, and 4,656 were genotyped using a custom
version of the Illumina OmniExpress. All individuals were phased
using Beagle 3.3.1 (Browning and Browning, 2007) and imputed
against 1,000 Genomes haplotypes (August 2010 release) using
Minimac (2011-10-27) (Howie et al., 2012). For the SNPs included
in Table 1, all had imputation r240.8. Minor allele frequencies for
the 24 SNPs in the replication samples are given in Supplementary
Table S2 online.
Statistical analysis
The Armitage trend test (Armitage, 1955) was used for the single-
marker analysis within the ‘‘Replication I’’ sample as implemented in
the INTERSNP software package (Herold et al., 2009). Only those
SNPs that passed the following quality criteria were included in the
analysis: minor allele frequency 41%, and deviation from Hardy–
Weinberg equilibrium P-values (PHWE) in cases 40.001 and in
controls 40.05. Single-marker analysis for the ‘‘Replication II’’
sample was performed using logistic regression with allele dosages
from imputation and including five principal components as covari-
ates to control for differences in ancestry. One SNP, rs7349332, was
directly genotyped but not present in the 1,000 Genomes imputation
reference panel; for this SNP, we performed logistic regression using
the observed genotypes. All tested SNPs had PHWE 40.01 across the
tested individuals, rounding imputed allele dosages to the nearest
genotype. A fixed-effects model (de Bakker et al., 2008) and
a random-effects model (Higgins et al., 2003) were used to perform
a meta-analysis of the data of all three studies (meta-analysis,
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‘‘Replication I,’’ and ‘‘Replication II’’). To obtain OR estimates for the
combined analysis, the allelic OR of the single studies were weighted
according to their standard errors, and significance was assessed
using the standard normal distribution (de Bakker et al., 2008).
The total variance Q was computed according to Cochrane (1954),
and the between-study variance I2 was calculated as sug-
gested by Higgins et al. (2003). I2 was used to determine whether a
fixed-effects model or a random-effects model was appropriate. In
case I2 was significant after adjustment for the number of SNPs tested
(n¼ 24), a random-effects model was used instead of the fixed-effects
model. However, we did not find evidence for heterogeneity across
studies for the significant loci. We used the established significance
threshold for GWAS of 5 10 8 (Frazer et al., 2007). Interaction
analysis was carried out within an extended case–control sample of
4,737 AGA patients and 4,159 controls from the 23andMe genomic
service. A model with a ‘‘g1*g2’’ term was fitted and then tested for
significance of the g1:g2 interaction by analysis of variance.
Expression analysis
DNA from the whole blood and RNA from the occipital hair follicles
of 98 population-based German controls (age 20–40 years) were
collected. Total RNA was extracted from human hair follicles
(RNeasy Micro Kit, Qiagen, Hilden, Germany). The quality and
quantity of the RNA were analyzed on a NanoDrop ND-1000
spectrophotometer (Peqlab Biotechnologie, Erlangen, Germany).
RNA samples were additionally checked for degradation via gel
electrophoresis in a BioAnalyzer 2100 (Agilent Technologies, Wald-
bronn, Germany) using RNA 6000 nano lab chips, according to the
manufacturer’s instructions. The Illumina TotalPrep-96 RNA Amplifi-
cation Kit (Illumina) was used for the amplification and biotinylation
of the RNA. Subsequent array-based gene expression analysis of
individual tissue samples was performed on Illumina’s human HT-
12v4 Expression BeadChips using standard protocols (Illumina). The
obtained fluorescence expression data were background subtracted
and quantile normalized using the GenomeStudio software (Illumina).
In the analysis of gene expression within human hair follicle, the AVG
signal and the detection P-value were taken into account. Genes were
assumed to be reliably expressed if the detection P-value waso0.01.
If a gene or different transcripts of a gene were detected by more than
one Illumina probe, the probe with the best expression values based
on all samples tested was analyzed. Nonpresent fluorescence inten-
sity after background subtraction or expression with detection P-value
40.01 was marked as ‘‘—’’ and defined as not expressed (Table 2).
To calculate genotype-specific expression, only those samples that
showed detection P-values of o0.01 were taken into account. DNA
extraction and genotyping was performed as described above.
Genotype-specific expression levels were calculated from the normal-
ized AVG signals for the respective gene-specific probe relative to the
expression levels of individuals with the AGA nonrisk genotype,
which was set to 100%. The R software (version 2.10.1; http://
www.R-project.org) was used for the statistical analysis, and P-values
were calculated using a one-sided t-test.
Association with hair curl
To analyze for a potential etiological overlap between AGA and hair
curl, we investigated all known AGA susceptibility loci for association
with hair curl and vice versa. Hair curl was assessed and association
tests were performed as previously described by Eriksson et al. (2010)
using data from 29,353 unrelated individuals of European ancestry.
We tested lead SNPs from a total of 12 AGA loci—the 8 loci identified
in our previous meta-analysis (Li et al., 2012) and the 4 additional loci
identified in this study—for association with hair curl.
CONFLICT OF INTEREST
VM is a full-time employee of GSK; JYT, NE, and DAH have stock options in
23andMe; AKK is an employee of 23andMe.
ACKNOWLEDGMENTS
The study was supported by the Life & Brain GmbH. We thank all participants
for their voluntary participation in this research study. We thank Lucie Florin
for her technical assistance in extracting DNA, and Christine Schmael for her
revision of the manuscript. Moreover, we thank all additional members of
the MAAN consortium: Hreinn Stefansson, Daniel Glass, Sarah E Medland,
Maria Dimitriou, Dawn Waterworth, Frank Geller, Veronique Bataille, Sibylle
Eigelshoven, Sandra Hanneken, Susanne Moebus, Martin den Heijer, Grant W
Montgomery, Panos Deloukas, Andrew C Heath, Patrick Sulem, Massimo
Mangino, Peter Vollenweider, and Tim D Spector. RCB is the recipient of a
Heisenberg Professorship from the German Research Foundation (DFG).
MMN is the recipient of a grant from the Alfried Krupp von Bohlen und
Halbach-Stiftung.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Adaimy L, Chouery E, Megarbane H et al. (2007) Mutation in WNT10A is
associated with an autosomal recessive ectodermal dysplasia: the
odonto-onycho-dermal dysplasia. Am J Hum Genet 81:821–8
Andl T, Reddy ST, Gaddapara T et al. (2002) WNT signals are required for
the initiation of hair follicle development. Dev Cell 2:643–53
Armitage P (1955) Tests for linear trends in proportions and frequencies.
Biometrics 11:375–86
Bohring A, Stamm T, Spaich C et al. (2009) WNT10A mutations are a frequent
cause of a broad spectrum of ectodermal dysplasias with sex-biased
manifestation pattern in heterozygotes. Am J Hum Genet 85:97–105
Brockschmidt FF, Heilmann S, Ellis JA et al. (2011) Susceptibility variants
on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for
male-pattern baldness. Br J Dermatol 165:1293–302
Brockschmidt FF, Hillmer AM, Eigelshoven S et al. (2010) Fine mapping of the
human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol
162:899–903
Browning SR, Browning BL (2007) Rapid and accurate haplotype phasing and
missing-data inference for whole-genome association studies by use of
localized haplotype clustering. Am J Hum Genet 81:1084–97
Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149:
1192–205
Cochrane WG (1954) The combination of estimates from different
experiments. Biometrics 10:101–29
Courtois M, Loussouarn G, Hourseau C et al. (1994) Hair cycle and alopecia.
Skin Pharmacol 7:84–9
de Bakker PI, Ferreira MA, Jia X et al. (2008) Practical aspects of
imputation-driven meta-analysis of genome-wide association studies.
Hum Mol Genet 17:R122–8
Ellis JA, Harrap SB (2001) The genetics of androgenetic alopecia. Clin
Dermatol 19:149–54
Ellis JA, Sinclair R, Harrap SB (2002) Androgenetic alopecia: pathogenesis and
potential for therapy. Expert Rev Mol Med 4:1–11
Eriksson N, Macpherson JM, Tung JY et al. (2010) Web-based, parti-
cipant-driven studies yield novel genetic associations for common traits.
PLoS Genet 6:e1000993
Frazer KA, Ballinger DG, Cox DR et al. (2007) A second generation human
haplotype map of over 3.1 million SNPs. Nature 449:851–61
S Heilmann et al.
Androgenetic Alopecia and WNT Signaling
www.jidonline.org 1495
Fuchs E (2007) Scratching the surface of skin development. Nature 445:834–42
Hamilton JB (1942) Male hormone stimulation is a prerequisite and an incitant
in common baldness. Am J Anat 71:451–80
Hamilton JB (1951) Patterned loss of hair in man; types and incidence.
Ann NY Acad Sci 53:708–28
Hayes VM, Severi G, Eggleton SA et al. (2005) The E211 G4A androgen
receptor polymorphism is associated with a decreased risk of metastatic
prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers
Prev 14:993–6
Herold C, Steffens M, Brockschmidt FF et al. (2009) INTERSNP: genome-wide
interaction analysis guided by a priori information. Bioinformatics
25:3275–81
Higgins JP, Thompson SG, Deeks JJ et al. (2003) Measuring inconsistency in
meta-analyses. BMJ 327:557–60
Hillmer AM, Brockschmidt FF, Hanneken S et al. (2008a) Susceptibility
variants for male-pattern baldness on chromosome 20p11. Nat Genet
40:1279–81
Hillmer AM, Flaquer A, Hanneken S et al. (2008b) Genome-wide scan and
fine-mapping linkage study of androgenetic alopecia reveals a locus on
chromosome 3q26. Am J Hum Genet 82:737–43
Hillmer AM, Hanneken S, Ritzmann S et al. (2005) Genetic variation in the
human androgen receptor gene is the major determinant of common
early-onset androgenetic alopecia. Am J Hum Genet 77:140–8
Howie B, Fuchsberger C, Stephens M et al. (2012) Fast and accurate genotype
imputation in genome-wide associaton studies through pre-phasing. Nat
Genet 44:955–9
Kaufman KD (2002) Androgens and alopecia. Mol Cell Endocrinol 198:89–95
Levy-Nissenbaum E, Bar-Natan M, Frydman M et al. (2005) Confirmation of
the association between male pattern baldness and the androgen receptor
gene. Eur J Dermatol 15:339–40
Li YH, Zhang K, Ye JX et al. (2011) Wnt10b promotes growth of hair
follicles via a canonical Wnt signalling pathway. Clin Exp Dermatol
36:534–40
Li R, Brockschmidt FF, Kiefer AK et al. (2012) Six novel susceptibility Loci for
early-onset androgenetic alopecia and their unexpected association
with common diseases. PLoS Genet 8:e1002746
Logan CY, Nusse R (2004) The Wnt signaling pathway in development and
disease. Annu Rev Cell Dev Biol 20:781–810
Medland SE, Nyholt DR, Painter JN et al. (2009) Common variants in
the trichohyalin gene are associated with straight hair in Europeans.
Am J Hum Genet 85:750–5
Millar SE, Willert K, Salinas PC et al. (1999) WNT signaling in the control of
hair growth and structure. Dev Biol 207:133–49
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for
extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Norwood OT (1975) Male pattern baldness: classification and incidence. South
Med J 68:1359–65
Nyholt DR, Gillespie NA, Heath AC et al. (2003) Genetic basis of male pattern
baldness. J Invest Dermatol 121:1561–4
Prodi DA, Pirastu N, Maninchedda G et al. (2008) EDA2R is associated with
androgenetic alopecia. J Invest Dermatol 128:2268–70
Randall VA (2007) Hormonal regulation of hair follicles exhibits a biological
paradox. Semin Cell Dev Biol 18:274–85
Reddy S, Andl T, Bagasra A et al. (2001) Characterization of Wnt gene
expression in developing and postnatal hair follicles and identification of
Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis.
Mech Dev 107:69–82
Rexbye H, Petersen I, Iachina M et al. (2005) Hair loss among elderly men:
etiology and impact on perceived age. J Gerontol A Biol Sci Med Sci
60:1077–82
Richards JB, Yuan X, Geller F et al. (2008) Male-pattern baldness susceptibility
locus at 20p11. Nat Genet 40:1282–4
Sato-Miyaoka M, Hisatsune C, Ebisui E et al. (2012) Regulation of hair
shedding by the type 3 IP(3) receptor. J Invest Dermatol 132:2137–47
Shimizu H, Morgan BA (2004) Wnt signaling through the beta-catenin pathway
is sufficient to maintain, but not restore, anagen-phase characteristics of
dermal papilla cells. J Invest Dermatol 122:239–45
Wang HY, Malbon CC (2004) Wnt-frizzled signaling to G-protein-coupled
effectors. Cell Mol Life Sci 61:69–75
Whiting DA (1993) Diagnostic and predictive value of horizontal sections of
scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad
Dermatol 28:755–63
S Heilmann et al.
Androgenetic Alopecia and WNT Signaling
1496 Journal of Investigative Dermatology (2013), Volume 133
